AstroCardia has developed a heart-on-a-chip to study cardiovascular aging… in space! Trials will begin in 2025 aboard the International Space Station (ISS). The MEDVIA project was made possible thanks to the combined expertise of the five Belgian partners: Space Applications Services, the Belgian Nuclear Research Center (SCK CEN), QbD Group, BIO INX, and Antleron.
Belgian Prof. Jan Rabaey has spent the past 35 years conducting pioneering tech research at the University of California at Berkeley. His groundbreaking electronics work has been used in a range of modern devices, including the iPad, brain-computer interfaces, and wireless sensor nodes used for the Internet of Things. The ongoing theme of his work has been miniaturization and connection, which he is now using to link technology and people like never before.
Flanders is home to one of the world’s most innovative agrifood clusters, and Johan Cardoen has been a central figure in that ecosystem for over three decades. From leading positions in agtech startups to the Managing Director of VIB, Cardoen has run the gamut of Flemish biotech. Interested in his decades of firsthand experience in the sector, we spoke with Cardoen about his views on the past, present, and future of sustainable agriculture.
Biodevice-CRO is a MEDVIA project uniting three very different, but complementary, Flemish companies: ICsense, Comate, and Antleron. This unique partnership aims to provide life science actors with customizable, modular bioprocess solutions through a collaborative Contract Research Organization (CRO) model. These smart solutions – the biodevice based on an integrated chip, biofluidic cartridge, and functional device – will enable fast-track development of personalized medicines and improved diagnostics.
Instantly turning water into beer may sound like a biblical miracle, but that’s exactly what Belgian start-up Bar.on is now doing. Their ‘molecular beer printer’ takes mere seconds to turn water into different styles of beer, with customized bitterness, alcohol content, fruitiness, and sweetness. Backed by science, the company is on a mission to make the beer industry more sustainable and hopes to soon roll out its molecular beer mixing technology to different markets.
Rapidly spreading diseases and unpredictable global shifts cause increased strain to the pharmaceutical supply chain, jeopardizing the secure delivery of drugs to those who are in need. Artificial intelligence can maximize efficacy of the value chain and allow optimal responses to changing market demands. Two experts share insights into the possibilities and hurdles associated with integration of machine learning tools into the pharmaceutical supply chain.
OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and epigenetic profiling, as well as companion diagnostics, the company uses second- and third-generation sequencing technology to enable scientific insights and build assays for better drug and therapy development. With both a wet lab and dry lab in house, OHMX.bio offers a full-circle service to biotech and pharma partners.
Byteflies is on a mission to make virtual care available to all. The Belgian company has developed a platform for remote patient monitoring solutions, to save precious time for healthcare providers, reduce hospitalization costs, and boost the quality of life for patients. The aim is to aid the transition from fragmented to connected healthcare, enabling a continuum of care through virtual solutions.
Patient data can be extremely helpful for improving health. If properly utilized, valuable insights can be generated, leading to better care for all. To do this, we need a way to overcome the incompatibility of information systems used by different healthcare providers, so that we are able to conduct large-scale research projects using data from multiple sources. The key to this lies in implementing data standards, such as OMOP and FHIR – specific methods developed for the storage, sharing, and interpretation of healthcare data.
CoMoveIT is a striking example of how visionary ideas can be turned into life-changing innovations once the right technology becomes available. We spoke with CoMoveIT’s CTO, Sotirios Gakopoulos, about the Belgian company’s unique solution to improve the mobility of patients with complex movement disorders, like cerebral palsy.
AstroCardia has developed a heart-on-a-chip to study cardiovascular aging… in space! Trials will begin in 2025 aboard the International Space Station (ISS). The MEDVIA project was made possible thanks to the combined expertise of the five Belgian partners: Space Applications Services, the Belgian Nuclear Research Center (SCK CEN), QbD Group, BIO INX, and Antleron.
Belgian Prof. Jan Rabaey has spent the past 35 years conducting pioneering tech research at the University of California at Berkeley. His groundbreaking electronics work has been used in a range of modern devices, including the iPad, brain-computer interfaces, and wireless sensor nodes used for the Internet of Things. The ongoing theme of his work has been miniaturization and connection, which he is now using to link technology and people like never before.
Flanders is home to one of the world’s most innovative agrifood clusters, and Johan Cardoen has been a central figure in that ecosystem for over three decades. From leading positions in agtech startups to the Managing Director of VIB, Cardoen has run the gamut of Flemish biotech. Interested in his decades of firsthand experience in the sector, we spoke with Cardoen about his views on the past, present, and future of sustainable agriculture.
Biodevice-CRO is a MEDVIA project uniting three very different, but complementary, Flemish companies: ICsense, Comate, and Antleron. This unique partnership aims to provide life science actors with customizable, modular bioprocess solutions through a collaborative Contract Research Organization (CRO) model. These smart solutions – the biodevice based on an integrated chip, biofluidic cartridge, and functional device – will enable fast-track development of personalized medicines and improved diagnostics.
Instantly turning water into beer may sound like a biblical miracle, but that’s exactly what Belgian start-up Bar.on is now doing. Their ‘molecular beer printer’ takes mere seconds to turn water into different styles of beer, with customized bitterness, alcohol content, fruitiness, and sweetness. Backed by science, the company is on a mission to make the beer industry more sustainable and hopes to soon roll out its molecular beer mixing technology to different markets.
Rapidly spreading diseases and unpredictable global shifts cause increased strain to the pharmaceutical supply chain, jeopardizing the secure delivery of drugs to those who are in need. Artificial intelligence can maximize efficacy of the value chain and allow optimal responses to changing market demands. Two experts share insights into the possibilities and hurdles associated with integration of machine learning tools into the pharmaceutical supply chain.
OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and epigenetic profiling, as well as companion diagnostics, the company uses second- and third-generation sequencing technology to enable scientific insights and build assays for better drug and therapy development. With both a wet lab and dry lab in house, OHMX.bio offers a full-circle service to biotech and pharma partners.
Byteflies is on a mission to make virtual care available to all. The Belgian company has developed a platform for remote patient monitoring solutions, to save precious time for healthcare providers, reduce hospitalization costs, and boost the quality of life for patients. The aim is to aid the transition from fragmented to connected healthcare, enabling a continuum of care through virtual solutions.
Patient data can be extremely helpful for improving health. If properly utilized, valuable insights can be generated, leading to better care for all. To do this, we need a way to overcome the incompatibility of information systems used by different healthcare providers, so that we are able to conduct large-scale research projects using data from multiple sources. The key to this lies in implementing data standards, such as OMOP and FHIR – specific methods developed for the storage, sharing, and interpretation of healthcare data.
CoMoveIT is a striking example of how visionary ideas can be turned into life-changing innovations once the right technology becomes available. We spoke with CoMoveIT’s CTO, Sotirios Gakopoulos, about the Belgian company’s unique solution to improve the mobility of patients with complex movement disorders, like cerebral palsy.